Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast Cancer

NCT00372476 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Imatinib and Vinorelbine

Sponsor

Novartis Pharmaceuticals